Doctolib
PrivateLast Round
Secondary
Apr 2, 2026
Est. Valuation
$3.89B
Total Funding Raised
$815.35M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Doctolib is a healthcare technology company that provides an online platform for patients to book medical appointments and offers practice management software for healthcare professionals.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, EHR & EMR, Vertical SaaS, Patient Engagement, NLP & Conversational AI
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Doctolib Comparables
Compare Doctolib with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Groupe NEHS | 81% | |
| DocPlanner | 81% | |
| Cegedim | 78% |
Doctolib Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Secondary | Apr 2, 2026 | ||||
| Series F | Mar 15, 2022 | ||||
| Series E | Mar 20, 2019 | ||||
| Series D | Nov 28, 2017 | ||||
| Series C | Jan 26, 2017 | ||||
Series B | Oct 13, 2015 |
Doctolib Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | Series E |
| Salica Investments | Secondary |
| Idinvest Partners | Series C |
| Kerala Ventures | Series A, Seed |
| Generation Investment Management | Secondary |
| A.P. Moller Holding | Secondary |
| ATHOS KG | Secondary |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2026
Platform books billions of appointments annually.
- Jul 14, 2026
Platform used for over 2 million prescriptions weekly.
Recent news
Latest coverage and updates
- is_developingOct 14, 2026
Doctolib says new capital supports developing in-house AI tools while it retains complete control of patient records.
- has_valuationOct 13, 2026
Doctolib has a $6.49B valuation, while an Apr '26 secondary sale values Doctolib at €3.6B, a 38% discount to its €5.8B valuation after its 2022 raise.
- is_developingOct 13, 2026
With Nvidia's investment, Doctolib aims to further develop its own artificial intelligence-based solutions and models in Europe, as announced in France on Oct 13th '26.
- has_valuationOct 13, 2026
Doctolib has a $4.03B valuation, equivalent to about €3.6 billion in an Apr '26 secondary sale, down from €5.8 billion in 2022.
- hiresSep 22, 2026
Doctolib hired Sanche d'Abravanel as Key Account & Partnerships Director on Jul 1st '14.
Doctolib Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Doctolib's valuation, stock price, and market status.
Is Doctolib a public or private company?
Doctolib is a private company.
What is the current stock price of Doctolib?
Doctolib is a private company, so its shares have no public market price. Caplight tracks Doctolib's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Doctolib worth (valuation)?
Doctolib's valuation is estimated at $3.9B based on funding round data.
Can I buy Doctolib stock?
Doctolib shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Doctolib's last funding round?
Doctolib's most recent funding round was Secondary on April 2, 2026.
Who are the main investors in Doctolib?
Key investors in Doctolib include Bpifrance, Eurazeo, General Atlantic, Accel.
Will Doctolib IPO soon?
No public IPO plans have been announced for Doctolib.
How can I track Doctolib secondary market activity?
Caplight tracks bids, offers, and trades in Doctolib's shares on secondary markets.